Phase 2 First Line Therapy Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients

Acute Myeloid LeukemiaFirst Line Therapy

Chinese PLA General Hospital160 enrolled1 locationNCT06928376

Recruiting

Phase 2

Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

MetastasesHER2 + Gastric CancerFirst Line Therapy+2 more

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest80 enrolled20 locationsNCT07176312

Recruiting

Phase 1Phase 2

Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer

Gastric (Stomach) CancerGastric AdenocarcinomaGEJ Adenocarcinoma+3 more

Henan Cancer Hospital45 enrolled1 locationNCT07334431